Retrospective Register for Uveal Melanoma

Uveal Melanoma Clinical Trial

Official title:

Retrospective Register for Uveal Melanoma

Clinical Trial Details — Status: Recruiting

Administrative data

• NCT number: NCT05733728
• Other study ID #: 1942/2022
• Status: Recruiting
• Start date: January 23, 2023
• Est. completion date: December 31, 2030

Study information

• Verified date: May 2023
• Source: Medical University of Vienna
• Contact: Reinhard Told
• Phone: +4314040048470
• Email: reinhard.told[@]meduniwien.ac.at
• Is FDA regulated: No
• Study type: Observational [Patient Registry]

Clinical Trial Summary

Background: Uveal melanoma (UM) is a common primary ocular malignancy associated with limited overall survival in the advanced stage of the disease. Fundamental breakthrough regarding the management of the disease and the overall-survival have not yet been achieved. Studies with large cohorts are difficult to perform due to limited patient numbers, therefore retrospective analyses are of great potential to gain further knowledge in a disease with high clinical needs. Aim: The proposed project is a register for patients with UM treated at the Department of Ophthalmology and Optometry at the Medical University of Vienna between 01.01.1997 and 31.12.2021. Patients and Methods: Patients treated for UM at the Department of Ophthalmology and Optometry at the Medical University of Vienna between 01.01.1997 and 31.12.2021 will be included in the register. Information on the baseline characteristics, survival times and course of the disease will be gathered via retrospective chart review and saved in a password-secured database.

Recruitment information / eligibility

• Status: Recruiting
• Enrollment: 1400
• Est. completion date: December 31, 2030
• Est. primary completion date: December 31, 2030
• Accepts healthy volunteers: No
• Gender: All
• Age group: 18 Years to 99 Years

Eligibility

Inclusion Criteria

• Patients 18 - 99 years
• Diagnosis of uveal melanoma Exclusion Criteria
• Patients younger than 18 years of age
• Inadequate or missing information on the clinical course in patient charts

Related Conditions & MeSH terms

• Melanoma
• Uveal Melanoma
• Uveal Neoplasms

Intervention

Other:
• any therapy suitable
any therapy suitable

Locations

Country	Name	City	State
Austria	Medical University of Vienna	Vienna

Sponsors (1)

Lead Sponsor	Collaborator
Medical University of Vienna

Country where clinical trial is conducted

Austria, 

Outcome

Type	Measure	Description	Time frame	Safety issue
Primary	Conduction of a Register providing the basis for	Retrospective studies analyzing the obtained data and easy identification of patients for prospective studies (e.g. long-term survival analysis)	1997-2021